Premarket trading on U.S. equities showed a broad mix of moves in large-cap names as investors digested fresh regulatory filings and strategic deal announcements, according to CNBC. The move leadership was split between sharp declines and notable gains driven by company-specific news and activist or strategic interests.
Regeneron Pharmaceuticals led the downside, with shares falling more than 11% after its late-stage treatment for a skin cancer missed goals in a pivotal trial. The disappointment underscores ongoing risk to the company’s pipeline and near-term milestones, traders said.
In contrast, Macy’s rose nearly 4% after a regulatory filing revealed Berkshire Hathaway had initiated a small stake in the department store, roughly $55 million at the end of the first quarter. The relatively modest size suggests the investment is not a large shift for Berkshire, and market chatter centered on whether investment lieutenant Ted Weschler could be the actor behind the move and what it might signal about consumer exposure at Berkshire’s equity sleeve.
Dominion Energy climbed more than 12% after NextEra Energy announced an all-stock transaction to acquire the utility company. NextEra said the combination would create the world’s largest regulated electric utility business, a deal viewed as a potential catalyst for scale advantages, capital allocation, and regulatory positioning in the sector.
Bio-Rad Laboratories surged about 13% following a Wall Street Journal report that Elliott Investment Management has built a sizable stake in the company. Details on the stake size and the activist’s plans were not disclosed in the report, leaving investors weighing potential governance or strategic changes.
Arm Holdings traded down roughly 1% after a Bloomberg report said the U.S. Federal Trade Commission is probing whether the chip maker is illegally monopolizing parts of the market. The development adds regulatory scrutiny risk to a stock that has been a focal point in AI and semiconductor discussions.
Delta Air Lines advanced more than 1% after Berkshire Hathaway disclosed a sizable stake in the airline, totaling about $2.6 billion. The move is notable given Warren Buffett’s six-year stance of moving Berkshire’s equity portfolio away from airlines, a shift traders will watch for implications on sentiment toward the travel sector.
UnitedHealth Group fell more than 3.5% after Berkshire Hathaway sold shares of the insurer in the first quarter, according to the same regulatory filing. The sale adds to a broader diversification dynamic within Berkshire’s holdings that investors are monitoring for implications on portfolio concentration and health-insurance exposure.
Salesforce slipped about 1% after Bank of America initiated coverage with an underperform rating, arguing the company faces a structural reset tied to artificial intelligence that could weigh on growth. Conversely, ServiceNow rose more than 4% as Bank of America reinitiated coverage with a buy rating, contending the software firm is likely to benefit from AI rather than be subsumed by it.
Crypto platform shares were weaker as Bitcoin prices slid more than 5% over the weekend, dipping below 77,000 for the first time since early May. Coinbase and Robinhood fell more than 2% and near 2%, respectively, amid the broader risk-off tone in crypto-linked equities tied to the move in digital-asset prices.
Ford Motor also joined the positive cohort, rising more than 6.5% after Ford Energy and EDF North America announced a five-year agreement to produce up to four gigawatt hours of direct current Block Battery energy storage systems annually. Deliveries are expected to begin in 2028, a development that could aid the automaker’s broader electrification and energy-management initiatives.
Key takeaways
- Stock moves: Regeneron off >11%; Macy’s up ~4%; Dominion up >12%; Arm down ~1%; Delta up >1%; UnitedHealth down >3.5%; Salesforce off ~1%; ServiceNow up >4%; Ford up >6.5%.
- Catalysts: A mix of trial results, strategic deals, activist stake signals, and regulatory filings; crypto price moves influenced crypto-exposed platforms.
- Implications: The day highlights how a blend of pipeline risk, deal-driven re-rating, and activist/governance signals can drive selective stock sentiment, with broader themes around AI, energy transition, and regulatory scrutiny shaping outcomes.
What drove the move
- Regeneron’s decline stems from a late-stage trial miss for a skin-cancer therapy, raising questions about pipeline momentum and potential implications for future approvals and commercialization timelines.
- Dominion Energy’s surge followed NextEra Energy’s all-stock offer to acquire the company, a combination that would reorganize the U.S. regulated-utility landscape and create scale advantages in a capital-intensive sector.
- The Macy’s uptick reflects Berkshire Hathaway’s small-quarterly stake disclosure in the retailer, suggesting selective exposure amidst a broader portfolio rotation rather than a broad reweighting of consumer-facing equities.
- Bio-Rad’s leap was driven by reports of Elliott Investment Management taking a sizable stake, signaling potential targeted activism or strategic review though specifics were not disclosed.
- Arm, UnitedHealth, and Salesforce moves reflect a confluence of regulatory risk, portfolio rebalancing by Berkshire, and AI-driven growth vs. structural headwinds themes in major software and healthcare names.
- Ford’s energy-storage alliance with EDF points to continued push into grid-scale storage solutions and battery-infrastructure initiatives that align with the broader energy transition story.
- Bitcoin’s drop weighed on Coinbase and Robinhood, underscoring the sensitivity of crypto-exposed platforms to digital-asset price volatility amid a weekend pullback.
Market reaction
The premarket tapestry suggests a market parsing idiosyncratic catalysts rather than a single directional impulse. The weakness in Regeneron highlights the risk-reward recalibration around high-profile biotech programs when late-stage data disappoints. Conversely, the Dominion-NextEra discord highlight growth in sector consolidation narratives and potential regulatory and capital-allocation benefits from scale in the utilities space. Activist signaling around Bio-Rad and capital-allocations tied to Berkshire’s evolving portfolio underscore the ongoing appetite for governance-driven moves and selective exposure to consumer and financials.
What analysts are saying
Analysts noted the breadth of the day’s movers underscores how investors are balancing company-specific data with macro and policy signals. The reactions to Berkshire’s airline stake and its portfolio activity suggest attention to Berkshire’s strategic posture toward cyclicals and defensives, while AI-driven coverage shifts weigh on software peers like Salesforce and ServiceNow in contrasting directions depending on the stance of major banks’ research notes. The energy-storage agreement at Ford raises visibility for utility-scale and consumer-electrification initiatives at automakers, potentially reinforcing a multi-year capex cycle in energy infrastructure.
Bigger picture
Across the market, investors are weighing a mix of corporate earnings narratives, regulatory developments, and the evolving stance on AI-related productivity improvements. The energy-transition push remains a structural theme supporting utility-scale storage projects and collaborative deals, while the regulatory red flags around tech hardware and financial services organizations keep a lid on indiscriminate upside in some tech names. The crypto-linked weakness keeps headlines focused on how digital-asset volatility can spill into stock prices of related platforms, even as consumer and healthcare names show resilience depending on company-specific catalysts.
What to watch next: investors will be looking to upcoming earnings reports and guidance, further regulatory filings, and any new commentary on AI strategies and capital allocation. Market participants will also monitor how Berkshire Hathaway adjusts exposure across airlines, healthcare, and consumer discretionary stocks, alongside developments in energy storage and utility consolidation as the sector rethinks its mix of assets and regulatory risk appetite.
— CNBC’s Yun Li contributed reporting.
